L'Occitane International S.A. (0973.HK)
HKD 33.8
(0.3%)
HKD 33.8
(0.3%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.54 Billion EUR | 19.08% |
| 2022 | 2.13 Billion EUR | 19.83% |
| 2021 | 1.78 Billion EUR | 15.83% |
| 2020 | 1.53 Billion EUR | -6.46% |
| 2019 | 1.64 Billion EUR | 15.22% |
| 2018 | 1.42 Billion EUR | 8.15% |
| 2017 | 1.31 Billion EUR | -0.29% |
| 2016 | 1.32 Billion EUR | 3.16% |
| 2015 | 1.28 Billion EUR | 8.9% |
| 2014 | 1.17 Billion EUR | 11.66% |
| 2013 | 1.05 Billion EUR | 1.1% |
| 2012 | 1.04 Billion EUR | 14.22% |
| 2011 | 913.44 Million EUR | 18.28% |
| 2010 | 772.29 Million EUR | 26.14% |
| 2009 | 612.24 Million EUR | 13.94% |
| 2008 | 537.33 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q4 | 734.95 Million EUR | 0.0% |
| 2023 Q1 | 536.01 Million EUR | -13.14% |
| 2023 Q2 | 536.01 Million EUR | 0.0% |
| 2023 FY | 2.54 Billion EUR | 19.08% |
| 2023 Q3 | 734.95 Million EUR | 37.12% |
| 2022 Q3 | 617.09 Million EUR | 37.05% |
| 2022 Q2 | 450.25 Million EUR | 0.0% |
| 2022 FY | 2.13 Billion EUR | 19.83% |
| 2022 Q1 | 450.25 Million EUR | -17.0% |
| 2022 Q4 | 617.09 Million EUR | 0.0% |
| 2021 Q3 | 542.46 Million EUR | 55.78% |
| 2021 Q1 | 348.21 Million EUR | -24.4% |
| 2021 Q2 | 348.21 Million EUR | 0.0% |
| 2021 Q4 | 542.46 Million EUR | 0.0% |
| 2021 FY | 1.78 Billion EUR | 15.83% |
| 2020 FY | 1.53 Billion EUR | -6.46% |
| 2020 Q1 | 308.31 Million EUR | -32.75% |
| 2020 Q2 | 308.31 Million EUR | 0.0% |
| 2020 Q3 | 460.6 Million EUR | 49.39% |
| 2020 Q4 | 460.6 Million EUR | 0.0% |
| 2019 Q3 | 458.46 Million EUR | 26.1% |
| 2019 FY | 1.64 Billion EUR | 15.22% |
| 2019 Q4 | 458.46 Million EUR | 0.0% |
| 2019 Q2 | 363.57 Million EUR | 0.0% |
| 2019 Q1 | 363.57 Million EUR | -12.55% |
| 2018 FY | 1.42 Billion EUR | 8.15% |
| 2018 Q4 | 415.74 Million EUR | 0.0% |
| 2018 Q3 | 415.74 Million EUR | 39.66% |
| 2018 Q1 | 297.69 Million EUR | -22.79% |
| 2018 Q2 | 297.69 Million EUR | 0.0% |
| 2017 Q2 | 274.1 Million EUR | 0.0% |
| 2017 FY | 1.31 Billion EUR | -0.29% |
| 2017 Q3 | 385.57 Million EUR | 40.67% |
| 2017 Q4 | 385.57 Million EUR | 0.0% |
| 2017 Q1 | 274.1 Million EUR | -28.94% |
| 2016 Q4 | 385.75 Million EUR | 0.0% |
| 2016 Q3 | 385.75 Million EUR | 39.85% |
| 2016 Q2 | 275.83 Million EUR | 0.0% |
| 2016 Q1 | 275.83 Million EUR | -25.04% |
| 2016 FY | 1.32 Billion EUR | 3.16% |
| 2015 Q4 | 367.98 Million EUR | 0.0% |
| 2015 FY | 1.28 Billion EUR | 8.9% |
| 2015 Q1 | 273.34 Million EUR | -21.0% |
| 2015 Q2 | 273.34 Million EUR | 0.0% |
| 2015 Q3 | 367.98 Million EUR | 34.62% |
| 2014 Q2 | 242.93 Million EUR | 0.0% |
| 2014 FY | 1.17 Billion EUR | 11.66% |
| 2014 Q4 | 346 Million EUR | 0.0% |
| 2014 Q1 | 242.93 Million EUR | -20.15% |
| 2014 Q3 | 346 Million EUR | 42.42% |
| 2013 FY | 1.05 Billion EUR | 1.1% |
| 2013 Q1 | 223.18 Million EUR | -24.87% |
| 2013 Q2 | 223.18 Million EUR | 0.0% |
| 2013 Q3 | 304.25 Million EUR | 36.33% |
| 2013 Q4 | 304.25 Million EUR | 0.0% |
| 2012 Q4 | 297.06 Million EUR | 0.0% |
| 2012 Q1 | 224.61 Million EUR | -1.64% |
| 2012 Q2 | 224.61 Million EUR | 0.0% |
| 2012 Q3 | 297.06 Million EUR | 32.26% |
| 2012 FY | 1.04 Billion EUR | 14.22% |
| 2011 Q4 | 228.36 Million EUR | 0.0% |
| 2011 FY | 913.44 Million EUR | 18.28% |
| 2011 Q1 | 193.07 Million EUR | 0.0% |
| 2011 Q2 | 193.07 Million EUR | 0.0% |
| 2011 Q3 | 228.36 Million EUR | 18.28% |
| 2010 FY | 772.29 Million EUR | 26.14% |
| 2010 Q4 | 193.07 Million EUR | 0.0% |
| 2010 Q3 | 193.07 Million EUR | 26.14% |
| 2010 Q2 | 153.06 Million EUR | 0.0% |
| 2010 Q1 | 153.06 Million EUR | 0.0% |
| 2009 Q4 | 153.06 Million EUR | 0.0% |
| 2009 Q2 | 134.33 Million EUR | 0.0% |
| 2009 Q1 | 134.33 Million EUR | 0.0% |
| 2009 FY | 612.24 Million EUR | 13.94% |
| 2009 Q3 | 153.06 Million EUR | 13.94% |
| 2008 FY | 537.33 Million EUR | 0.0% |
| 2008 Q3 | 134.33 Million EUR | 0.0% |
| 2008 Q4 | 134.33 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 336.01 Million HKD | -656.496% |
| Innovative Pharmaceutical Biotech Limited | 6.59 Million HKD | -38455.149% |
| China Overseas Nuoxin International Holdings Limited | 180.99 Million HKD | -1304.426% |
| Prosperous Future Holdings Limited | 470.33 Million HKD | -440.457% |
| Huasheng International Holding Limited | 565.9 Million HKD | -349.181% |
| Fourace Industries Group Holdings Limited | 268.02 Million HKD | -848.401% |
| Evergreen Products Group Limited | 979.24 Million HKD | -159.583% |
| EC Healthcare | 4.21 Billion HKD | 39.636% |
| Ming Fai International Holdings Limited | 2.06 Billion HKD | -22.961% |
| Blue Moon Group Holdings Limited | 7.32 Billion HKD | 65.291% |
| SuperRobotics Holdings Limited | 15.08 Million HKD | -16755.255% |
| Takbo Group Holdings Limited | 215.59 Million HKD | -1079.057% |
| Hyfusin Group Holdings Limited | 866.25 Million HKD | -193.442% |